Literature DB >> 18523352

Emerging role of uterine natural killer cells in establishing pregnancy.

Vijay Kumar1, Bikash Medhi.   

Abstract

Normal pregnancy has been considered as a controlled state of inflammation at an early stage of blastocyst implantation that subsequently develops systemically. Till recent past most popular hypotheses regarding status of immune system in pregnancy were dominated by the Th1 and Th2 hypothesis, in which the fetus avoids maternal rejection through a bias towards T-helper (Th2) cytokine production. Recent findings have shown that predominant immune interactions in the human deciduas are between the placental trophoblast and maternal uterine natural killer (uNK) cells rather than the T cells. Thus NK cells are emerging as important players in the uterine immune response to invasive forms of placenta, as in cases of hemochorial placenta. In humans there is a lack of evidence for T-cell responses to trophoblast cells; therefore it was thought that uterine NK cells are the key factors by which the maternal immune system recognizes trophoblast cells. In this review we are trying to summarize the role of uNK cells in the maintenance of normal pregnancy in humans.

Entities:  

Mesh:

Year:  2008        PMID: 18523352     DOI: IJIv5i2A1

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  4 in total

Review 1.  Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

Authors:  V Kumar
Journal:  Purinergic Signal       Date:  2012-12-28       Impact factor: 3.765

2.  Serum adenosine deaminase and its isoenzyme activities in pregnancy.

Authors:  Göksel Bahadır; Yasemin Erdoğan Döventaş; Rana Turkal; Macit Koldaş; Filiz Basınoğlu; Banu Dane; Emine Altunkaynak
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

3.  Immunopharmacology of ulipristal as an emergency contraceptive.

Authors:  Ralph P Miech
Journal:  Int J Womens Health       Date:  2011-11-22

Review 4.  Toll-like receptors in immunity and inflammatory diseases: Past, present, and future.

Authors:  Kumar Vijay
Journal:  Int Immunopharmacol       Date:  2018-05-04       Impact factor: 4.932

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.